Skip to content
  • Start
  • News
  • Video
  • Podcast
  • Event
  • Premium
    • Premium Content
    • VC Database
    • Company Database
    • Soft Funding & Grants
    • Job Database
  • About BioStock
Log in Subscribe
Home / VYVGART

VYVGART

FDA

Fewer approvals in 2022 from cautious FDA

After approving an average of 51 drugs per year since 2017, there have been only 37 FDA approvals...

Myasthenia gravis attracts investment

Growing interest in myasthenia gravis

Traditionally, rare diseases have gone under the big...

BioStock

  • Start
  • News
  • Video
  • Podcast
  • Event
  • About BioStock
  • Privacy Policy
  • Terms and Conditions

Read BioStock's newsletter

Get industry news, company information and invitations to BioStock events directly in your inbox!

Val*
This field is used for validation purposes and should be left unchanged.
© 2025 Biostock